159 related articles for article (PubMed ID: 32663595)
1. Design and Investigation of Penetrating Mechanism of Octaarginine-Modified Alginate Nanoparticles for Improving Intestinal Insulin Delivery.
Li M; Sun Y; Ma C; Hua Y; Zhang L; Shen J
J Pharm Sci; 2021 Jan; 110(1):268-279. PubMed ID: 32663595
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid.
Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y
Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869
[TBL] [Abstract][Full Text] [Related]
3. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
4. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles].
Liu XL; Zhang WJ; Wei G; Lu WY
Yao Xue Xue Bao; 2012 Apr; 47(4):512-6. PubMed ID: 22799036
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulin.
Zhang ZH; Zhang YL; Zhou JP; Lv HX
Int J Nanomedicine; 2012; 7():3333-9. PubMed ID: 22848162
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
[TBL] [Abstract][Full Text] [Related]
7. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
8. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery.
Zhang YW; Tu LL; Tang Z; Wang Q; Zheng GL; Yin LN
Pharm Dev Technol; 2021 Nov; 26(9):943-952. PubMed ID: 34372745
[TBL] [Abstract][Full Text] [Related]
9. A Nanocomposite Vehicle Based on Metal-Organic Framework Nanoparticle Incorporated Biodegradable Microspheres for Enhanced Oral Insulin Delivery.
Zhou Y; Liu L; Cao Y; Yu S; He C; Chen X
ACS Appl Mater Interfaces; 2020 May; 12(20):22581-22592. PubMed ID: 32340452
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
[TBL] [Abstract][Full Text] [Related]
11. A cell-penetrating peptide mediated chitosan nanocarriers for improving intestinal insulin delivery.
Li L; Yang L; Li M; Zhang L
Carbohydr Polym; 2017 Oct; 174():182-189. PubMed ID: 28821057
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway.
Zheng Y; Wu J; Shan W; Wu L; Zhou R; Liu M; Cui Y; Zhou M; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34039-34049. PubMed ID: 30207680
[TBL] [Abstract][Full Text] [Related]
13. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs.
Xing L; Zheng Y; Yu Y; Wu R; Liu X; Zhou R; Huang Y
J Mater Chem B; 2021 Feb; 9(6):1707-1718. PubMed ID: 33496710
[TBL] [Abstract][Full Text] [Related]
14. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang Z; Lv H; Zhou J
Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
[TBL] [Abstract][Full Text] [Related]
15. Dual crosslinking of folic acid-modified pectin nanoparticles for enhanced oral insulin delivery.
Zhang F; Pei X; Peng X; Gou D; Fan X; Zheng X; Song C; Zhou Y; Cui S
Biomater Adv; 2022 Apr; 135():212746. PubMed ID: 35929218
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin.
Cheng H; Cui Z; Guo S; Zhang X; Huo Y; Mao S
Acta Biomater; 2021 Nov; 135():506-519. PubMed ID: 34487859
[TBL] [Abstract][Full Text] [Related]
17. Design of self-polymerized insulin loaded poly(n-butylcyanoacrylate) nanoparticles for tunable oral delivery.
Cheng H; Zhang X; Qin L; Huo Y; Cui Z; Liu C; Sun Y; Guan J; Mao S
J Control Release; 2020 May; 321():641-653. PubMed ID: 32097672
[TBL] [Abstract][Full Text] [Related]
18. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.
Xu Y; Zheng Y; Wu L; Zhu X; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(11):9315-9324. PubMed ID: 29484890
[TBL] [Abstract][Full Text] [Related]
19. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
Urimi D; Agrawal AK; Kushwah V; Jain S
AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
[TBL] [Abstract][Full Text] [Related]
20. [In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides].
Li CC; Zhang ZH; Zhang YL; Lü HX; Zhou JP
Yao Xue Xue Bao; 2013 Jan; 48(1):131-7. PubMed ID: 23600154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
